National Advertising Division Finds Certain Claims for OLLY's Lovin' Libido Supplement Supported; Recommends Sensation Claim be Discontinued
However, the National Advertising Division (NAD) recommended that Olly discontinue its Lovin' Libido claim related to sensation.
Bayer and Olly are competitors that each market a variety of dietary supplements to consumers. Bayer challenged claims made by Olly that touted the sexual benefits of Olly's Lovin' Libido product that relate to ashwagandha, an ingredient in the product.
NAD reviewed Olly's advertising to determine whether it conveyed the message that the Lovin' Libido product, rather than the individual ingredient ashwagandha, provided the claimed benefits.
Of the eight express claims, five specifically named ashwagandha as providing the expected benefit. The three remaining challenged claims did not specifically reference ashwagandha, but appear in contexts that make clear that ashwagandha is the source of the claimed benefits. NAD determined that in this context, reasonable consumers would interpret the claims as attributing the product benefits to ashwagandha.
Based on Olly's express messaging in its ads, NAD further determined that the Lovin' Libido product is marketed towards women who are uninterested in and unsatisfied with sex. NAD reviewed the evidence to determine if it supported a reasonable basis that ashwagandha provides the claimed benefits to that target population of women.
In support of its claims, Olly provided seven randomized clinical trials (RCTs) studying the sexual health benefits of ashwagandha root extract. NAD determined that one study did not adequately support the claimed sexual health benefits due to its focus on perimenopausal women and thus could not qualify as competent and reliable support for the challenged claims. NAD found that the six additional studies provided a reasonable basis for Olly's claims about the sexual health benefits of ashwagandha in its Lovin' Libido product. However, NAD noted that none of the RCTs directly addressed the specific claimed benefit of enhanced 'sensation.'
Accordingly, NAD determined that Olly provided a reasonable basis for its claims related to desire, drive, arousal, satisfaction and lubrication, but determined that the studies are not a good fit to support claims related to sensation and recommended that the reference to sensation be discontinued.
During the proceeding, Olly voluntarily discontinued certain Lovin' Libido claims. Therefore, NAD did not review these claims on their merits and will treat them, for compliance purposes, as though NAD recommended they be discontinued.
In its advertiser statement, Olly stated that it will comply with NAD's recommendations.
All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for advertising or promotional purposes.
About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, promote fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.
About the National Advertising Division: The National Advertising Division of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. The National Advertising Division reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and promoting fair competition for business.
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Ahmedabad Plane Crash
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
6 days ago
- Associated Press
Niagen Bioscience to Present at Canaccord Genuity's 45th Annual Growth Conference
LOS ANGELES--(BUSINESS WIRE)--Aug 4, 2025-- Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Ozan Pamir, will participate in Canaccord Genuity's 45th Annual Growth Conference, taking place from August 12 to 14, 2024, in Boston. Mr. Fried is scheduled to participate in a fireside chat on Tuesday, August 12, at 12:00 p.m. Eastern Time (9:00 a.m. Pacific Time). To register for the Niagen Bioscience fireside chat webcast, please visit Mr. Fried and Mr. Pamir will also hold one-on-one meetings with institutional investors throughout the conference. To arrange a meeting, please visit the conference website here or contact your CG representative. A replay of the fireside chat webcast will be available on the Niagen Bioscience Investor Relations website, following the event. For additional information on Niagen Bioscience, visit About Niagen Bioscience: Niagen Bioscience, Inc. (NASDAQ: NAGE), formerly ChromaDex Corp., is the global leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. As a trusted pioneer of NAD+ discoveries, Niagen Bioscience ™ is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. The Niagen Bioscience team, composed of world-renowned scientists, works with independent investigators from esteemed universities and research institutions around the globe to uncover the full potential of NAD+. A vital coenzyme found in every cell of the human body, NAD+ declines with age and exposure to everyday lifestyle stressors. NAD+ depletion is a key contributor to age-related changes in health and vitality. Distinguished by state-of-the-art laboratories, rigorous scientific and quality protocols, and collaborations with leading research institutions worldwide, Niagen Bioscience sets the gold standard for research, quality, and innovation. There's a better way to age. At the heart of its clinically proven product portfolio is Niagen ® (patented nicotinamide riboside, or NR), the most efficient, well-researched, high-quality, and legal NAD+ booster available. Niagen powers the Company's consumer supplement, Tru Niagen ®, the number one NAD+ boosting oral supplement in the United States † (available at ), and Niagen Plus ™, featuring pharmaceutical-grade intravenous (IV) and injectable Niagen products ( ). Pharmaceutical-grade Niagen IV and injections are compounded and distributed by U.S. FDA-registered 503B outsourcing facilities and are available exclusively at clinics with a prescription. Niagen Bioscience's robust patent portfolio protects NR and other NAD+ precursors. Niagen Bioscience maintains a website at where copies of press releases, news, and financial information are regularly published. †Based on the top-selling dietary supplement brands by revenue per the largest U.S. e-commerce marketplace (as of 1/1/2024 - 12/31/2024). View source version on CONTACT: Niagen Bioscience Media Contact: Kendall Knysch, Senior Director of Media Relations & Partnerships 310.405.5227 [email protected] Bioscience Investor Relations Contact: ICR, LLC Reed Anderson (646) 277-1260 Stephanie Carrington (646) 277-1282 [email protected] KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH SCIENCE PHARMACEUTICAL RESEARCH SOURCE: Niagen Bioscience, Inc Copyright Business Wire 2025. PUB: 08/04/2025 08:32 AM/DISC: 08/04/2025 08:32 AM
Yahoo
01-08-2025
- Yahoo
purelyIV Launches Niagen® IV Therapy - A Breakthrough in NAD+ Cellular Wellness
Metro Detroit's leading mobile IV therapy provider introduces pharmaceutical-grade Niagen® infusions, offering a faster, more efficient, and more comfortable way to boost NAD+ levels at home. ROCHESTER HILLS, Mich., Aug. 1, 2025 /PRNewswire/ -- purelyIV, Metro Detroit's leading mobile IV therapy provider, is proud to announce the launch of Niagen® IV Therapy, a groundbreaking new service designed to efficiently boost NAD+ levels. This innovative treatment uses pharmaceutical-grade nicotinamide riboside chloride (NR) to deliver a faster, more comfortable NAD+ replenishment experience compared to traditional NAD+ IV infusions. Niagen® IV Therapy offers clients a cutting-edge approach to cellular health and wellness. Clinical studies show that Niagen® infusions raise whole-blood NAD+ levels 20% higher than standard NAD+ IV treatments and achieve peak levels within just three hours—while requiring 75% less infusion time. Treatments are typically completed in 30–45 minutes, allowing for a more convenient experience with fewer side effects. "Niagen® IV Therapy represents the next evolution of NAD+ boosting wellness," said Erin Boumansour, co-founder and lead practitioner at purelyIV. "We are excited to bring this advanced therapy to Metro Detroit, offering our clients an efficient and scientifically supported option to enhance energy, support cognitive health, and promote healthy aging—all delivered in the comfort of their home or office." purelyIV's licensed nurses administer Niagen® IV infusions in 500mg and 1000mg doses with 500ml of fluids and electrolytes. Clients can also choose add-on options like NiagenH IV Push and Niagen® Shots for a quick, convenient boost during other IV treatments. With its mobile, in-home service model and commitment to clinical excellence, purelyIV continues to lead the way in providing premium IV therapy solutions designed to meet the unique wellness goals of each client. To learn more about Niagen® IV Therapy or to schedule an appointment, visit Contact:Michael Boumansour***@ Photo(s): Press release distributed by PRLog View original content: SOURCE purelyIV Sign in to access your portfolio
Business Insider
30-07-2025
- Business Insider
Country music star Zac Brown's weight-loss plan includes gaming, IV drips, and several foods he says he won't eat again
Fortnite, NAD, no seed oil — country musician Zac Brown 's approach to health isn't what you'd expect. In an interview with GQ published on Tuesday, the front man of the Zac Brown Band spoke about how his diet and fitness routine have helped him transform his body. Brown told GQ he's cut out gluten, dairy, sugar, and alcohol from his diet, and he now reads all food labels carefully. His diet is simple and involves "a lot of paleo, vegetables, good, clean proteins, whole foods, things that aren't just processed in a bag or in a box," Brown said. "It's based on three meals a day that are about four hours apart. After your last meal, you fast for 14 hours," he said. Brown added that clean eating requires discipline and commitment, something that he still struggles with, especially when he's on press tours and working on new music. However, even small changes in his diet — like cutting out seed oil — can make a big difference in how he feels. "The kind of oil that you intake, only avocado, olive, or coconut oil. That cuts out a lot, on top of those other restrictions. Everything has some kind of seed oil in it, sunflower oil or canola oil or something," Brown said. "Once your psychology gets around feeling good, then that gives you a lot of strength to just sacrifice things," he added. In recent years, there have been various claims that seed oils cause inflammation and are bad for health. However, nutritionists and health scientists tell Business Insider that the reality is more nuanced. Blaming seed oil also overlooks the bigger culprits behind chronic diseases. "There are things that are way more important for you than to even think about seed oils," Dariush Mozaffarian, a cardiologist, told BI. "I want people to be avoiding super processed foods and to be avoiding refined flours and sugars." Diet aside, Brown says he gets his bloodwork done every month with a regenerative medicine doctor. "On top of that, I've been doing stem cells to help regenerate, and I've been taking peptides. I take NAD. I do a monthly IV with some exosomes and NAD in it. I take my vitamins and my supplements," Brown said. NAD, or nicotinamide adenine dinucleotide, is a molecule found in living cells that's required for energy production and cellular repair. As natural NAD production declines with age, NAD+ boosters have become a popular fix in the longevity and biohacking world. As for his workouts, Brown said he built a trailer outfitted with a full gym for when he's on tour. It's inspired by a tip he once got from Bruce Springsteen. "He said, 'I sweat for an hour a day, no matter where I am, what I'm doing, I sweat for an hour a day.' He's like, 'It'll change your life.' I started doing that when I was home or even on the road," Brown said. Brown says he's also found a clever hack to make his cardio sessions more bearable. "I have an overactive brain, so being able to play 'Madden' or 'Fortnite' while I'm on the Arc Trainer for an hour, it makes an hour go by like that," Brown said. "In my mind, I'm like, I'm going to go down and play a game. I'm not thinking, I'm going to go down and torture myself with an hour of cardio." Brown says he's lost over 60 pounds from his peak weight. "I'm probably a little under 200 right now. 265 was the biggest. I was a big boy," he added. A representative for Brown did not immediately respond to a request for comment sent by BI outside regular hours.
